Literature DB >> 7514019

An XRF study of trace elements accumulation in kidneys of tumor-bearing mice after treatment with cis-DDP with and without selenite and selenocistamine.

C Shenberg1, M Boazi, J Cohen, A Klein, M Kojler, A Nyska.   

Abstract

The effect of cis-DDP treatment with and without selenite and selenocistamine was studied on kidneys of tumor-bearing mice. The amounts of cis-DDP, selenite, and selenocistamine injected were chosen so as to be compatible with the treatment of humans. The animals were sacrificed at 7, 14, and 28 d after treatment. The kidneys were removed and subjected to trace element analysis by a novel X-ray fluorescence (XRF) method and for pathological assessment. The results show that following treatment with cis-DDP, K, Fe, Cu, and Zn reach a maximum level after 7 d; K, Fe, and Cu levels were significantly reduced by the addition of selenite. The level of Zn was reduced only in groups treated with selenite whereas that of K and Cu was reduced also in groups treated with selenocistamine with and without cis-DDP. The greatest increase in Pt and Se levels was reached 1 wk after injection with cis-DDP, with and without selenocompounds, and in the case of Pt was partly reduced by addition of selenite. Se returned to control values 2 wk after injection, although Pt was still high in all groups 2 and 4 wk after injection. The results corroborate the findings of our previous studies. The effect of selenocistamine in cis-DDP treated mice was partly insufficient. The pathological examination of the kidneys did not show any differences in the effect of various additives during the study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514019     DOI: 10.1007/bf02950787

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  9 in total

1.  Effect of selenite on the toxicity of cis-DDP in mice: estimation of trace elements.

Authors:  C Shenberg; T Izak-Biran; M Mantel; B Rachmiel; J Weininger; S Chaitchik
Journal:  J Trace Elem Electrolytes Health Dis       Date:  1989-06

2.  A new family of water-soluble, third generation antitumor platinum complexes.

Authors:  P Bitha; S G Carvajal; R V Citarella; E F Delos Santos; F E Durr; J J Hlavka; S A Lang; H L Lindsay; J P Thomas; R E Wallace
Journal:  J Med Chem       Date:  1989-09       Impact factor: 7.446

3.  Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.

Authors:  G S Baldew; J G McVie; M A van der Valk; G Los; J J de Goeij; N P Vermeulen
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

4.  Selenium supplementation increases renal glomerular filtration rate.

Authors:  G C Guidi; G Bellisola; G Bonadonna; F Manzato; O Ruzzenente; R Schiavon; S Galassini; Q X Liu; H R Shao; G Moschini
Journal:  J Trace Elem Electrolytes Health Dis       Date:  1990-09

5.  [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].

Authors:  Y Araya
Journal:  Hokkaido Igaku Zasshi       Date:  1990-05

6.  Cis DDP in combination with selenium and sulfur. Subcellular effect in kidney cells. Electron microprobe study.

Authors:  J P Berry; G Lespinats
Journal:  J Submicrosc Cytol Pathol       Date:  1988-01

7.  Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.

Authors:  J P Berry; C Pauwells; S Tlouzeau; G Lespinats
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

8.  Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.

Authors:  M Satoh; A Naganuma; N Imura
Journal:  J Pharmacobiodyn       Date:  1989-04

9.  The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.

Authors:  K Ohkawa; Y Tsukada; H Dohzono; K Koike; Y Terashima
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

  9 in total
  2 in total

1.  The distribution of BrK alpha/RbK alpha peak intensity ratio in human whole blood samples. Comparison between normal and colorectal cancer cases.

Authors:  C Shenberg; S Spiegel; S Chaitchik; P Jordan; M Kitzis; M Altman; Y Cohen; M Boazi
Journal:  Biol Trace Elem Res       Date:  1994-09       Impact factor: 3.738

2.  Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stress.

Authors:  Ahmed E Abdel Moneim; Mohamed S Othman; Ahmed M Aref
Journal:  Biomed Res Int       Date:  2014-08-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.